Erasca Inc

Research Erasca Inc (ERAS) on Bullrun: market cap USD 5.69B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerERAS
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.69B
• Financial periodFY2025
• Net income-USD 124.55M
• Free cash flow-USD 95.58M

Valuation Snapshot

latest market cap is USD 5.69B.

About Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes ERAS-0015, a pan-RAS molecular glue for the treatment of patients with RAS-mutated solid tumors; ERAS-4001, a pan-KRAS inhibitor for the treatment of patients with KRAS-mutated solid tumors;

Frequently asked questions

What is Erasca Inc's market cap?

Erasca Inc's market capitalization is USD 5.69B.

What does Erasca Inc do?

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.